Derangement of mucosal barrier function by bacteria colonizing the rat colonic mucosa

European Journal of Clinical Investigation

Volumn 28, Issue 12, 1998, Pages 1019-1026

  Garcia Lafuente A ^a   Antolin M ^a   Guarner, F ^a   Crespo, E ^a   Salas, A ^b   Forcada, P ^b   Malagelada, J R ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b HOSPITAL MÚTUA DE TERRASSA   (Spain)

Author keywords

Colitis; Flora; Inflammation; Permeability

Indexed keywords

ANTIBIOTIC AGENT; MYELOPEROXIDASE; PICRIC ACID; TRINITROBENZENESULFONIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COLITIS; COLON ABSORPTION; COLON INJURY; COLON MUCOSA; CONTROLLED STUDY; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBMUCOSA;

ANIMALS; GASTROINTESTINAL CONTENTS; IMMUNITY, MUCOSAL; INTESTINAL MUCOSA; MALE; PERMEABILITY; PICRATES; RATS; RATS, SPRAGUE-DAWLEY; SPECIFIC PATHOGEN-FREE ORGANISMS; TRINITROBENZENESULFONIC ACID;

EID: 0032449033     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1998.00405.x     Document Type: Article

References (25)

1. 1 Boedeker EC. Adherent bacteria: breaching the mucosal barrier? Gastroenterology 1994;106:255-6.
2. 2 Kindon H, Pothoulakis C, Thim L, Devaney K, Podolsky DK. Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotein. Gastroenterology 1995;109:516-23.
3. 3 Butler BD, Lichtenberger LM, Hills BA. Distribution of surfactants in the canine gastrointestinal tract and their ability to lubricate. Am J Physiol 1983;244:G645-G51.
4. 4 Mack DR, Neumann AW, Policova Z, Sherman PM. Surface hydrophobicity of the intestinal tract. Am J Physiol 1992;262:G171-G7.
5. 5 Tatsumi Y, Lichtenberger LM. Molecular association of trinitrobenzenesulfonic acid and surface phospholipids in the development of colitis in rats. Gastroenterology 1996;110: 780-9.
6. 6 Lugea A, Guarner F, Domingo A, Salas A, Malagelada J-R. The colonic surfactant is a key defensive barrier against macromolecules and toxins (abstract). Gastroenterology 1997;112:A380.
7. 7 Chadwick VS, Anderson RP. Microorganisms and their products in inflammatory bowel disease. In: McDermott RP, Stenson WF, editors. Inflammatory bowel disease New York: Elsevier; 1992. p. 241-58.
8. 8 García-Lafuente A, Antolín M, Guarner F, et al. Incrimination of anaerobic bacteria in the induction of experimental colitis. Am J Physiol 1997;272:G10-G15.
9. 9 Little JR, Eisen HN. Preparation and characterization of antibodies specific for the 2,4,6-trinitrophenyl group. Biochemistry 1966;5: 3385-95.
10. 10 Vilaseca J, Salas A, Guarner F, Rodríguez R, Malagelada JR. Participation of thromboxane and other eicosanoid synthesis in the course of experimental colitis. Gastroenterology 1990;98:269-77.
11. 11 Schierwagen C, Bylund-Fellenius AC, Lundberg C. Improved method for quantification of tissue PMN accumulation measured by myeloperoxidase activity. J Pharmacol Methods 1990;23:179-86.
12. 12 Garcia-Lafuente A, Antolín M, Guarner F, Vilaseca J, Malagelada JR. Bacterial peptides enhance inflammatory activity in a rat model of colitis. Digestion 1996;57:368-73.
13. 13 Spitz J, Hecht G, Taveras M, Aoys E, Alverdy J. The effect of dexamethasone administration on rat intestinal permeability: the role of bacterial adherence. Gastroenterology 1994;106: 35-41.
14. 14 Wells CL, Van de Westerlo EMA, Jechorek RP, Feltis BA, Wilkins TD, Erlandsen SL. Bacteroides fragilis enterotoxin modulates epithelial permeability and bacterial internalization by HT-29 enterocytes. Gastroenterology 1996;110: 1429-37.
15. 15 Grisham MB, Volkmer C, Tso P, Yamada T. Metabolism of trinitrobenzene sulfonic acid by the rat colon produces reactive oxygen species. Gastroenterology 1991;101:540-7.
16. 16 Yamada T, Deitch E, Specian RD, Perry MA, Sartor RB, Grisham MB. Mechanisms of acute and chronic intestinal inflammation induced by indomethacin. Inflammation 1993;17:641-62.
17. 17 Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya RA. Novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990;98:694-702.
18. 18 Videla S, Vilaseca J, Guarner F, et al. Role of intestinal microflora in chronic inflammation and ulceration of the rat colon. Gut 1994;35:1090-7.
19. lo T cells. Res Immunol 1994;145:357-62.
20. 20 Taurog JD, Richardson JA, Croft JT, et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med 1994;180: 2359-64.
21. 21 Kühn R, Löhler J, Rennick D, Rajewski K, Müller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993;75:263-74.
22. 22 Videla S, Vilaseca J, Guarner F, et al. Stimulation of mucosal inflammatory activity by the normal fecal flora in a rat model of colitis. Inflamm Bowel Dis 1997;3:191-7.
23. 23 Macpherson A, Khoo UY, Forgacs I, Philpott-Howard J, Bjarnason I. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut 1996;38:365-75.
24. 24 Morris GP, Beck PL, Herridge MS, Depew WT, Szewezuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989;96:795-803.
25. 25 Yamada T, Marshall S, Specian RD, Grisham MBA. Comparative analysis of two models of colitis in rats. Gastroenterology 1992;102:1524-34.